Filing Flows › LifeMD (LFMD) › Q2 2025
LifeMD (LFMD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 5, 2025
LifeMD (LFMD) reported revenue of $62.2M for the second quarter 2025 (Q2 2025), +23% from a year earlier and -5% from the quarter before. Operating margin was -1.5%, net loss $1.6M (2.5% of revenue).
LifeMD, Q2 2025: revenue $62.2M (+23% year over year), operating margin -1.5%, net loss $1.6M, operating cash flow $8.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $62.2M | -5% | +23% |
| Operating profit | −$907K | -136% | — |
| Net earnings | −$1.6M | -182% | — |
| Operating cash flow | $8.6M | +182% | +90% |
| Free cash flow | $5.8M | +447% | +50% |
What changed
Revenue was $62.2M in Q2 2025, up 23% year over year and down 5% from the previous quarter.
Gross margin was 88.1%, down 2.0 points from a year earlier. Operating costs exceeded revenue by $907K, an operating margin of -1.5%. Operating expenses grew 7% against revenue growth of 23%. The fastest-growing cost line was Other operating costs (+28%). The quarter ended with a net loss of $1.6M, after a profit of $1.9M the previous quarter. Net interest and other expense of $2.1M was the main reason.
Operating cash flow was $8.6M (up 90% year over year). Non-cash charges added back $437K of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items added $7.7M. Capital expenditures of $2.8M left free cash flow of $5.8M.
Questions
What was LifeMD's revenue in the second quarter 2025?
LifeMD (LFMD) reported revenue of $62.2M for the second quarter 2025 (Q2 2025), +23% from a year earlier and -5% from the quarter before.
Was LifeMD profitable in the second quarter 2025?
Operating loss was $907K (-1.5% of revenue) and net loss $1.6M.
Source: LifeMD 10-Q on SEC EDGAR.